Broker Center sponsored links

Hi-Tech Pharmacal gets FDA nod to market generic Penlac

Wed Sep 19, 2007 9:58am EDT
 
Email | Print | | Reprints | Single Page
[-] Text [+]

Sept 19 (Reuters) - Hi-Tech Pharmacal Co Inc (HITK.O: Quote, Profile, Research, Stock Buzz) said U.S. health regulators granted final approval for its Ciclopirox topical solution, a generic version of Dermik Laboratories' Penlac nail fungus treatment.

Penlac topical solution had sales of $87 million in 2006 based on IMS sales data, the maker of over-the-counter generic drugs added. (Reporting by Neha Pathania in Bangalore)

 

Help us advance this story. Provide relevant links or share your insights using our comment box. Please be considerate and help us by reporting any abuse you find. Reuters will delete comments that don't meet community standards.

Have a correction to this article? Email the editors

Featured Broker sponsored link

Editor's Choice

  • Pictures
  • Video
  • Articles
Photo

A selection of our best photos from the past 24 hours.  View Slideshow 

Most Popular on Reuters

  • Articles
  • Video
  • Recommended